NVCN News and Press, Neovasc Inc. From 05/13/21

Viewership of the 139 Channelchek videos released on Channelchek in 2020 was (and still are) through the roof. Looking back, this makes sense. After all, 2020 brought many new investors to the financial markets - Channelchek’s purpose is to provide information to investors at all levels...

VANCOUVER and MINNEAPOLIS - (NewMediaWire) - May 10, 2021 - Neovasc   Inc. (“Neovasc” or the “Company”) ( NASDAQ ,  TSX : NVCN) today announced that the first patient has been enrolled in the  CO ronary SI nus Reducer for the Treatment ...

VANCOUVER and MINNEAPOLIS – (NewMediaWire) – May 06, 2021 – Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), today reported financial results for the first quarter ended March 31, 2021. Read More >>

Neovasc Inc. (NVCN) Q1 2021 Earnings Conference Call May 6, 2021 4:30 PM ET Company Participants Mike Cavanaugh – Managing Director-Westwicke Fred Colen – President and Chief Executive Officer Chris Clark – Chief Financial Officer Conference Call Participants Danielle Ant...

Neovasc (NVCN): Q1 GAAP EPS of -$0.04 beats by $0.05.Revenue of $0.45M (-15.1% Y/Y) misses by $0.15M.Shares -1%.Press Release For further details see: Neovasc EPS beats by $0.05, misses on revenue

VANCOUVER and MINNEAPOLIS, May 06, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc, Inc. ("Neovasc" or the "Company") ( NASDAQ , TSX : NVCN), today reported financial results for the first quarter ended March 31, 2021. First Quarter Highlight...

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - April 28, 2021) - Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) ("Neovasc" or the "Company") today announced progress towards its value creation strategy of expanding global reimbursement for the Neovasc Reducer™ ("Re...

Vancouver, British Columbia and Minneapolis, Minnesota--(Newsfile Corp. - April 27, 2021) -   Neovasc Inc.  (NASDAQ: NVCN) (TSX: NVCN) will report financial results for the first quarter ended March 31, 2021 on Thursday, May 6, 2021. Neovasc President and Chief Executive Officer Fred...

The FDA approval process for vaccines, therapeutics, and other pharmaceuticals was on the nightly news through late 2020. Investors and non-investors alike developed some understanding of that FDA timeline. Medical device clearance is less understood yet critical for investors looking to benef...

VANCOUVER and MINNEAPOLIS, April 19, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc , Inc. ("Neovasc" or the "Company") ( NASDAQ , TSX : NVCN) today announced that the journal EuroIntervention has published an article entitled, “Coronary Sinus Reducer Im...